HORMONE-SECRETION BY DISPERSED CELL-CULTURES OF HUMAN PITUITARY-ADENOMAS - EFFECTS OF THEOPHYLLINE, THYROTROPIN-RELEASING-HORMONE, SOMATOSTATIN, AND 2-BROMO-ALPHA-ERGOCRYPTINE

被引:92
作者
ADAMS, EF [1 ]
BRAJKOVICH, IE [1 ]
MASHITER, K [1 ]
机构
[1] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT MED, ENDOCRINE UNIT, LONDON W12 0HS, ENGLAND
关键词
D O I
10.1210/jcem-49-1-120
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Basal and modulated secretion of PRL and GH by dispersed cell cultures of human somatotropic, lactotropic, and mixed somatotropic-lactotropic adenomas has been examined. Twenty-four-hour secretion of PRL by a normal pituitary, a lactotropic, and a mixed adenoma increased with time in culture. The secretion rate from a mixed adenoma had increased 18-fold by day 20 over that observed on day 1, 225 μg PRL being produced from 4 X 105 cells. PRL secretion was still elevated after 36 days of culture. GH secretion always decreased rapidly from day 1. Initial GH secretion in cultures of a somatotropic adenoma was 18-fold of that from the same number of normal pituitary cells. Theophylline (10‑2 M) significantly stimulated GH secretion by somatotropic and mixed adenoma cells during a 4-h incubation after 4 and 28, but not 49, days in culture. PRL secretion was only stimulated at 28 days. TRH stimulated PRL and GH secretion from adenomas in a dose-dependent manner, with 10 ng/ml TRH being maximal. Somatostatin alone at doses up to 100 ng/ml had no consistent effect on GH secretion but completely blocked the 2-fold stimulation induced by 10‑2 M theophylline. Bromocriptine (2-bromo-α-ergocryptine) inhibited basal PRL and GH secretion with increasing effects up to the maximum used (10 μg/ml) and virtually abolished the theophylline- induced stimulation of GH and PRL secretion at this dose. It is concluded that dispersed cell cultures of human pituitary adenomas can be satisfactorily maintained for at least 28 days, and, during this period, demonstrate autonomous secretion of PRL but not GH. The modulation of PRL and GH secretion by various agents indicates the value of this technique for the direct study of functioning human pituitary adenomas. © 1979 by The Endocrine Society.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 32 条
[1]  
[Anonymous], ANTERIOR PITUITARY
[2]   HUMAN GROWTH HORMONE IN CULTURES OF HUMAN PITUITARY TUMORS [J].
BATZDORF, U ;
GOLD, V ;
MATTHEWS, N ;
BROWN, J .
JOURNAL OF NEUROSURGERY, 1971, 34 (06) :741-&
[3]   GROWTH-HORMONE RELEASE INHIBITING HORMONE IN ACROMEGALY [J].
BESSER, GM ;
MORTIMER, CH ;
CARR, D ;
SCHALLY, AV ;
COY, DH ;
EVERED, D ;
KASTIN, AJ ;
TUNBRIDGE, WM ;
THORNER, MO ;
HALL, R .
BMJ-BRITISH MEDICAL JOURNAL, 1974, 1 (5904) :352-355
[4]   GALACTORRHEA - SUCCESSFUL TREATMENT WITH REDUCTION OF PLASMA PROLACTIN LEVELS BY BROM-ERGOCRYPTINE [J].
BESSER, GM ;
MCNEILLY, AS ;
EDWARDS, CRW ;
PARKE, L ;
FORSYTH, IA .
BRITISH MEDICAL JOURNAL, 1972, 3 (5828) :669-&
[5]   INHIBITION OF ADENOSINE-3',5'-MONOPHOSPHATE ACCUMULATION IN ANTERIOR-PITUITARY GLAND IN-VITRO BY GROWTH HORMONE-RELEASE INHIBITING HORMONE [J].
BORGEAT, P ;
LABRIE, F ;
DROUIN, J ;
BELANGER, A ;
IMMER, H ;
SESTANJ, K ;
NELSON, V ;
GOTZ, M ;
SCHALLY, AV ;
COY, DH ;
COY, EJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 56 (04) :1052-1059
[6]   BROMOCRIPTINE TREATMENT OF ACROMEGALY [J].
CASSAR, J ;
MASHITER, K ;
JOPLIN, GF .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (05) :539-546
[7]   PLASMA GROWTH-HORMONE RESPONSE TO THYROTROPIN-RELEASING HORMONE IN PATIENTS WITH ACTIVE ACROMEGALY [J].
FAGLIA, G ;
BECKPECC.P ;
FERRARI, C ;
TRAVAGLINI, P ;
AMBROSI, B ;
SPADA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 36 (06) :1259-1262
[8]   PROLACTIN PRODUCTION BY HUMAN ANTERIOR PITUITARY CULTURED IN-VITRO [J].
GALA, RR .
JOURNAL OF ENDOCRINOLOGY, 1971, 50 (04) :637-&
[9]  
GAUVTIK KM, 1976, BIOCHEM J, V158, P119
[10]   HUMAN FETAL PITUITARY IN CULTURE - HORMONE-SECRETION AND RESPONSE TO SOMATOSTATIN, LUTEINIZING-HORMONE RELEASING FACTOR, THYROTROPIN RELEASING FACTOR AND DIBUTYRYL CYCLIC-AMP [J].
GOODYER, CG ;
HALL, CSG ;
GUYDA, H ;
ROBERT, F ;
GIROUD, CJP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (01) :73-85